Literature DB >> 2837228

Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure.

E Lee1, M Hirouchi, M Hosokawa, H Sayo, M Kohno, K Kariya.   

Abstract

Myeloperoxidase and eosinophil peroxidase were isolated from the bone marrow cells of rats treated with or without propylthiouracil (PTU) which caused bone marrow depression. PTU treatment decreased the activity of myeloperoxidase but not of eosinophil peroxidase using guaiacol as the electron donor. However, when KI,N-N'-dimethyl-p-phenylenediamine and pyrogallol were used as the electron donor, the activity of only eosinophil peroxidase was inhibited by PTU treatment. EPR spectra indicated that the structure of myeloperoxidase surrounding the heme iron changed from a rhombic form into an axial one by the repeated administration of PTU. Therefore, the inactivation of peroxidases by PTU treatment was accompanied by an alteration of their structures surrounding the heme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837228     DOI: 10.1016/0006-2952(88)90574-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity.

Authors:  T Akamizu; S Ozaki; H Hiratani; H Uesugi; J Sobajima; Y Hataya; N Kanamoto; M Saijo; Y Hattori; K Moriyama; K Ohmori; K Nakao
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 2.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

Review 3.  ANCA-associated vasculitides--advances in pathogenesis and treatment.

Authors:  Min Chen; Cees G M Kallenberg
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

4.  Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Authors:  Hua Ye; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 5.  Drug-induced glomerular disease: immune-mediated injury.

Authors:  Jonathan J Hogan; Glen S Markowitz; Jai Radhakrishnan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

6.  Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.

Authors:  H Ye; M-H Zhao; Y Gao; X-H Guo; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 7.  Myeloperoxidase: a potential therapeutic target for coronary artery disease.

Authors:  Thanat Chaikijurajai; W H Wilson Tang
Journal:  Expert Opin Ther Targets       Date:  2020-05-07       Impact factor: 6.902

Review 8.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

9.  Benzylthiouracil-induced glomerulonephritis.

Authors:  Sihem Trimeche Ajmi; Rim Braham; Sarra Toumi; Molka Chadli Chaieb; Amel Maaroufi; Koussay Ach; Larbi Chaieb
Journal:  Case Rep Med       Date:  2009-07-06

10.  Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production.

Authors:  Yoshihiro Kusunoki; Daigo Nakazawa; Haruki Shida; Fumihiko Hattanda; Arina Miyoshi; Sakiko Masuda; Saori Nishio; Utano Tomaru; Tatsuya Atsumi; Akihiro Ishizu
Journal:  Front Immunol       Date:  2016-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.